Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Jeremy J Rose"'
Autor:
Rachel K. Rosenstein, Jeremy J. Rose, Stephen R. Brooks, Wanxia L. Tsai, Massimo Gadina, Steven Z. Pavletic, Keisuke Nagao, Edward W. Cowen
Publikováno v:
JID Innovations, Vol 4, Iss 2, Pp 100246- (2024)
Cutaneous sclerotic chronic graft-versus-host disease (cGVHD) is a common and highly morbid complication of allogeneic hematopoietic stem cell transplantation. Our goals were to identify signals active in the skin of patients with sclerotic cGVHD in
Externí odkaz:
https://doaj.org/article/a71dfe3324184830825d044026421d12
Autor:
Jonathan C. Poe, Jiyuan Fang, Dadong Zhang, Marissa R. Lee, Rachel A. DiCioccio, Hsuan Su, Xiaodi Qin, Jennifer Y. Zhang, Jonathan Visentin, Sonali J. Bracken, Vincent T. Ho, Kathy S. Wang, Jeremy J. Rose, Steven Z. Pavletic, Frances T. Hakim, Wei Jia, Amy N. Suthers, Itaevia M. Curry-Chisolm, Mitchell E. Horwitz, David A. Rizzieri, William C. McManigle, Nelson J. Chao, Adela R. Cardones, Jichun Xie, Kouros Owzar, Stefanie Sarantopoulos
Publikováno v:
JCI Insight, Vol 8, Iss 11 (2023)
Alloreactivity can drive autoimmune syndromes. After allogeneic hematopoietic stem cell transplantation (allo-HCT), chronic graft-versus-host disease (cGVHD), a B cell–associated autoimmune-like syndrome, commonly occurs. Because donor-derived B ce
Externí odkaz:
https://doaj.org/article/6512c743367141a7ad578b252db65faa
Autor:
Ana Caroline Costa-da-Silva, Marit H. Aure, Joshua Dodge, Daniel Martin, Susan Dhamala, Monica Cho, Jeremy J. Rose, Carol W. Bassim, Kiran Ambatipudi, Frances T. Hakim, Steven Z. Pavletic, Jacqueline W. Mays
Publikováno v:
iScience, Vol 25, Iss 1, Pp 103592- (2022)
Summary: Chronic graft-versus-host disease (cGVHD) targets include the oral mucosa and salivary glands after allogeneic hematopoietic stem cell transplant (HSCT). Without incisional biopsy, no diagnostic test exists to confirm oral cGVHD. Consequentl
Externí odkaz:
https://doaj.org/article/615891903b1847178ae5f937acbf9658
Autor:
James N. Kochenderfer, Frances T. Hakim, Ronald E. Gress, Shicheng Yang, Mark Raffeld, Jeremy J. Rose, Stefania Pittaluga, Moses O. Evbuomwan, Robert O. Carpenter
Purpose: Multiple myeloma is a usually incurable malignancy of plasma cells. New therapies are urgently needed for multiple myeloma. Adoptive transfer of chimeric antigen receptor (CAR)–expressing T cells is a promising new therapy for hematologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7de058c259eafcf018aca0cc1407cc34
https://doi.org/10.1158/1078-0432.c.6522453
https://doi.org/10.1158/1078-0432.c.6522453
Autor:
James N. Kochenderfer, Frances T. Hakim, Ronald E. Gress, Shicheng Yang, Mark Raffeld, Jeremy J. Rose, Stefania Pittaluga, Moses O. Evbuomwan, Robert O. Carpenter
PDF file - 90K, Anti-bcma2 transduced T cells from Myeloma Patient 4 produced TNF and IFN in a BCMA-specific manner.BCMA protein in solution does not block recognition of BCMA+ target cells by anti-bcma2-transduced T cells in vitro.Human BCMA protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdceada2a1c308092f2b341ca9b535e5
https://doi.org/10.1158/1078-0432.22452345.v1
https://doi.org/10.1158/1078-0432.22452345.v1
Autor:
Rachel K. Rosenstein, Jeremy J. Rose, Stephen R. Brooks, Wanxia L. Tsai, Massimo Gadina, Steven Z. Pavletic, Keisuke Nagao, Edward W. Cowen
Cutaneous sclerotic chronic graft-versus-host disease (cGVHD) is a common and highly morbid complication of allogeneic hematopoietic stem cell transplantation (HSCT). We identified genes that are significantly upregulated in the skin of sclerotic cGV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fea00ac58ca0330ba8d5d7fa1a8de5ac
https://doi.org/10.1101/2022.12.07.22283119
https://doi.org/10.1101/2022.12.07.22283119
Autor:
Jonathan C Poe, Jiyuan Fang, Dadong Zhang, Marissa R Lee, Rachel A DiCioccio, Hsuan Su, Xiaodi Qin, Jennifer Zhang, Jonathan Visentin, Sonali J Bracken, Vincent T Ho, Kathy S Wang, Jeremy J Rose, Steven Z Pavletic, Frances T Hakim, Wei Jia, Amy N Suthers, Itaevia Curry-Chisolm, Mitchell E Horwitz, David A Rizzieri, William McManigle, Nelson J Chao, Adela R Cardones, Jichun Xie, Kouros Owzar, Stefanie Sarantopoulos
Alloreactivity can drive autoimmune syndromes. After allogeneic hematopoietic stem cell transplantation (allo-HCT) chronic graft-versus-host disease (cGVHD), a B cell-mediated autoimmune-like syndrome, commonly occurs. Because donor-derived B cells c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c473db4c87738c7f0e79af6c6c5d1f7b
https://doi.org/10.1101/2022.10.13.512162
https://doi.org/10.1101/2022.10.13.512162
Autor:
Noa G. Holtzman, Dr. Annie P. Im, Alen Ostojic, Lauren M. Curtis, Laura Parsons-Wandell, Arlene Berman, Jeanette Nashed, Cody J. Peer, Annieka Reno, William Douglas Figg, M. Teresa Magone, Edward W. Cowen, Jacqueline W. Mays, Fran T. Hakim, Jeremy J. Rose, Seth M. Steinberg, Marie Pouzolles, Naomi Taylor, Dr. Steven Z. Pavletic
Publikováno v:
Transplantation and Cellular Therapy. 29:S251-S252
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0ecd16a0db0828eccf5a44d88f3ec5d
https://doi.org/10.1016/s2666-6367(23)00398-6
https://doi.org/10.1016/s2666-6367(23)00398-6
Autor:
Yueh-wei Shen, Allen Xue, Philippe Youkharibache, Mark Roschewski, Norris Lam, Jennifer N. Brudno, John J. Rossi, Lekha Mikkilineni, Brenna Hansen, Nathalie Scholler, Jeremy J. Rose, Robert M. Dean, Ronald E. Gress, Danielle Vanasse, Rashmika Patel, Steven A. Rosenberg, James N. Kochenderfer, Adrian Bot, David F. Stroncek, Raul E. Cachau
Publikováno v:
Nature Medicine. 26:270-280
Anti-CD19 chimeric antigen receptor (CAR)-expressing T cells are an effective treatment for B-cell lymphoma, but often cause neurologic toxicity. We treated 20 patients with B-cell lymphoma on a phase I, first-in-human clinical trial of T cells expre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::604629cfd78421e15a53797a91e21fe6
https://doi.org/10.1038/s41591-019-0737-3
https://doi.org/10.1038/s41591-019-0737-3
Autor:
Luigi D. Notarangelo, Alexandra F. Freeman, Jennifer S. Wilder, Veena Kapoor, Irini Sereti, Jeffrey I. Cohen, Harry L. Malech, Ronald E. Gress, Jennifer L. Sadler, Jennifer A. Kanakry, Ellen Carroll, Miranda M. Broadney, Jeremy J. Rose, Lauren R. Skeffington, Elizabeth Garabedian, Xiao-Yi Yan, Natalia S. Nunes, Amy P. Hsu, Seth M. Steinberg, Christopher G. Kanakry, Gulbu Uzel, Rochelle Fletcher, Steven M. Holland, Andrea Lisco, William G. Telford, Juan Gea-Banacloche, Nirali N. Shah, Mark Parta, Christa S. Zerbe, Daniel H. Fowler, Stephanie N. Hicks, Dimana Dimitrova, Thomas E. Hughes, Jenny E Blau
Publikováno v:
Biol Blood Marrow Transplant
Allogeneic blood or marrow transplantation (BMT) is a potentially curative therapy for patients with primary immunodeficiency (PID). Safe and effective reduced-intensity conditioning (RIC) approaches that are associated with low toxicity, use alterna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad197fd92f19071d59ac226e6423628e
https://doi.org/10.1016/j.bbmt.2019.08.018
https://doi.org/10.1016/j.bbmt.2019.08.018